Back
Taro Pharmaceutical Industries 10K Form
Sell
48
TARO
Taro Pharmaceutical Industries
Last Price:
36.11
Seasonality Move:
9.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TARO News And Ratings
See the #1 stock for the next 7 days that we like better than TARO
TARO Financial Statistics
Sales & Book Value
| Annual Sales: | $572.95M |
|---|---|
| Cash Flow: | $40.51M |
| Price / Cash Flow: | 5227.85 |
| Annual Sales: | $46.50 |
| Price / Book: | 0.79 |
Profitability
| EPS (TTM): | 0.61000 |
|---|---|
| Net Income (TTM): | $22.68M |
| Gross Margin: | $268.32M |
| Return on Equity: | 1.31% |
| Return on Assets: | 1.07% |
Taro Pharmaceutical Industries Earnings Forecast
Key Taro Pharmaceutical Industries Financial Ratios
- The Gross Profit Margin over the past 37 years for TARO is 46.83%.
- The Selling, General & Administrative Expenses for TARO have been equal to 34.62% of Gross Profit Margin.
- The Research & Development expenses have been 9.12% of Revenue.
- The Interest Expense is 4.91% of Operating Income.
- The Net Earning history of TARO is 4.44% of Total Revenues.
- Per Share Earnings over the last 36 years have been positive in 19 years.
Taro Pharmaceutical Industries Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Current Symbol: | TARO |
| CUSIP: | M8737E |
| Website: | taro.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 3.71 |
| Quick Ratio: | 3.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 54.21 |
|---|---|
| Forward P/E Ratio: | 0 |
TARO Technical Analysis vs Fundamental Analysis
Sell
48
Taro Pharmaceutical Industries (TARO)
is a Sell
Is Taro Pharmaceutical Industries a Buy or a Sell?
-
Taro Pharmaceutical Industries stock is rated a Sell
The current Taro Pharmaceutical Industries [TARO] share price is $36.86. The Score for TARO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.